RadNet Inc. logo

RadNet Inc. (PQIA)

Market Closed
5 Dec, 20:00
XSTU XSTU
67. 00
+1
+1.52%
- Market Cap
930.4 P/E Ratio
0% Div Yield
0 Volume
0.55 Eps
66
Previous Close
Day Range
67 69
Year Range
40.4 78
Want to track PQIA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 79 days

Summary

PQIA closed Friday higher at €67, an increase of 1.52% from Thursday's close, completing a monthly decrease of -3.6% or €2.5. Over the past 12 months, PQIA stock gained 0%.
PQIA is not paying dividends to its shareholders.
The last earnings report, released on Nov 10, 2025, missed the consensus estimates by -0.23%. On average, the company has fell short of earnings expectations by -0.21%, based on the last three reports. The next scheduled earnings report is due on Feb 26, 2026.
RadNet Inc. has completed 1 stock splits, with the recent split occurring on Nov 28, 2006.
The company's stock is traded on 6 different exchanges and in various currencies, with the primary listing on NASDAQ (NMS) (USD).

PQIA Chart

RadNet, Inc. (RDNT) Q3 2025 Earnings Call Transcript

RadNet, Inc. (RDNT) Q3 2025 Earnings Call Transcript

RadNet, Inc. ( RDNT ) Q3 2025 Earnings Call November 10, 2025 10:30 AM EST Company Participants Mark Stolper - Executive VP & CFO Howard Berger - Chairman, President & CEO Conference Call Participants David MacDonald - Truist Securities, Inc., Research Division Brian Tanquilut - Jefferies LLC, Research Division John Ransom - Raymond James & Associates, Inc., Research Division Andrew Mok - Barclays Bank PLC, Research Division Yuan Zhi - B. Riley Securities, Inc., Research Division James Sidoti - Sidoti & Company, LLC Presentation Operator Good morning, ladies and gentlemen, and welcome to the RadNet Inc. Third Quarter 2025 Financial Results Conference Call.

Seekingalpha | 4 weeks ago
RadNet (RDNT) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

RadNet (RDNT) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

While the top- and bottom-line numbers for RadNet (RDNT) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks | 4 weeks ago
Exploring Analyst Estimates for RadNet (RDNT) Q3 Earnings, Beyond Revenue and EPS

Exploring Analyst Estimates for RadNet (RDNT) Q3 Earnings, Beyond Revenue and EPS

Besides Wall Street's top-and-bottom-line estimates for RadNet (RDNT), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2025.

Zacks | 1 month ago

RadNet Inc. (PQIA) FAQ

What is the stock price today?

The current price is €67.00.

On which exchange is it traded?

RadNet Inc. is listed on NASDAQ (NMS).

What is its stock symbol?

The ticker symbol is PQIA.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, no market cap data is available.

What is the earnings per share?

The EPS is 0.2.

When is the next earnings date?

The next earnings report will release on Feb 26, 2026.

Has RadNet Inc. ever had a stock split?

RadNet Inc. had 1 splits and the recent split was on Nov 28, 2006.

RadNet Inc. Profile

Professional Services Industry
Industrials Sector
Howard G. Berger CEO
XSTU Exchange
US7504911022 ISIN
US Country
11,000 Employees
- Last Dividend
28 Nov 2006 Last Split
1 Jul 1986 IPO Date

Overview

RadNet, Inc., established in 1981 and headquartered in Los Angeles, California, establishes a prominent position in the United States healthcare infrastructure by providing comprehensive outpatient diagnostic imaging services. The company differentiates its offerings by structuring its operations into two primary segments: Imaging Centers and Artificial Intelligence. This dual-focused approach allows RadNet to cater to the diverse needs of healthcare providers and patients, ensuring both traditional and technologically advanced diagnostic solutions. Through its extensive network and innovative technology deployment, RadNet sets itself apart as a key contributor to the evolving landscape of diagnostic imaging services.

Products and Services

RadNet, Inc. offers a broad spectrum of diagnostic imaging and related services, alongside advanced AI technologies for image interpretation and screening. Below is an elaborated list of its products and services:

  • Magnetic Resonance Imaging (MRI): This service provides detailed images of organs and tissues within the body, utilizing magnetic fields and radio waves. MRI is pivotal for diagnosing a range of conditions, from brain disorders to musculoskeletal injuries.
  • Computed Tomography (CT): CT scans offer cross-sectional images of the body through the use of X-rays and computing algorithms. They are essential in detecting various diseases and conditions, including cancers, heart disease, and internal injuries.
  • Positron Emission Tomography (PET): PET scans, often used in conjunction with CT or MRI scans, provide metabolic and physiological data by detecting radioactive materials injected into the body. This is crucial for cancer diagnosis and monitoring, as well as neurological and cardiac applications.
  • Nuclear Medicine: This involves the use of small amounts of radioactive material to diagnose or treat diseases, including many types of cancers, heart disease, and other abnormalities within the body.
  • Mammography: Specializing in the early detection of breast cancer, mammography utilizes low-dose X-rays to examine breast tissue. This is a critical tool in breast cancer screening and diagnostics.
  • Ultrasound: Using sound waves to produce images of structures within the body, ultrasound services are essential for monitoring pregnancies, diagnosing pelvic and abdominal conditions, and guiding minimally invasive procedures.
  • Diagnostic Radiology: This encompasses a range of imaging modalities, including X-ray, fluoroscopy, and more, to diagnose diseases and conditions across the body.
  • Fluoroscopy: Providing real-time images of the movement of internal fluids, organs, or devices, fluoroscopy is vital for guiding various diagnostic and therapeutic procedures.
  • Multi-Modality Imaging Services: RadNet offers comprehensive imaging solutions that combine multiple diagnostic techniques to provide a holistic view of a patient’s health condition.
  • Computerized Systems for Image Distribution: The company develops advanced systems for the efficient distribution, display, storage, and retrieval of digital images, enhancing the flow of diagnostic information.
  • Picture Archiving Communications Systems (PACS) and Related Services: These systems and services are key to the management of digital imaging and electronic records, improving accessibility and efficiency in healthcare settings.
  • Artificial Intelligence Suites: RadNet develops and deploys AI technologies aimed at enhancing the interpretation of images related to breast, lung, and prostate, alongside providing AI solutions for prostate cancer screening. This technological advancement represents RadNet’s commitment to integrating cutting-edge technology within diagnostic practices.

Contact Information

Address: 1508, 1510 and 1516 Cotner Avenue
Phone: 310 478 7808